Skip to main content
ViGenCell Inc. logo

ViGenCell Inc. — Investor Relations & Filings

Ticker · 308080 ISIN · KR7308080001 KO Professional, scientific and technical activities
Open in API
Filings indexed 134 across all filing types
Latest filing 2025-12-24 Director's Dealing
Country KR South Korea
Listing KO 308080

About ViGenCell Inc.

https://www.vigencell.com/en/

ViGenCell Inc. is a biotechnology company specializing in the development of immune cell therapies. The company focuses on creating treatments for cancer and other incurable diseases by enhancing a patient's own immunity. Its core technologies include the ViTier platform, which utilizes antigen-specific killer T cells to target and remove cancer cells, and the ViRanger platform, a T-cell gene therapy technology. These proprietary platforms form the basis of its pipeline of novel immune cell therapeutics designed to prolong life and improve patient outcomes.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등거래계획보고서
Director's Dealing Classification · 98% confidence The document is a formal 'Report on Trading Plan for Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주특정증권등거래계획보고서) filed with the Korean financial authorities (Financial Supervisory Service/Korea Exchange). This document outlines a planned future transaction (disposal of shares) by a major shareholder (Boryung Corporation) in Vigencell Co., Ltd. Since this is a regulatory filing regarding a planned transaction in shares by a major shareholder, it falls under the category of 'Regulatory Filings' (RNS) as it does not fit into the specific 'Director's Dealing' (which usually refers to completed trades) or 'Major Shareholding Notification' (which refers to crossing ownership thresholds).
2025-12-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in accordance with Article 147 of the Capital Markets Act in South Korea. It details the shareholding status, changes in ownership, and contractual relationships (such as joint holding agreements) between the reporter (Gaeun Global) and special related parties (Boryung). This type of filing is specifically designed to notify the market of significant changes in share ownership that cross regulatory thresholds, which corresponds to the 'Major Shareholding Notification' category.
2025-12-24 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea (DART system) used when an individual or entity's shareholding in a company crosses a specific threshold (typically 5%). The document explicitly details the reporter's (Kim Tai Gyu) shareholding changes in 'Vigencell Co., Ltd.' due to market sales. This falls under the 'Major Shareholding Notification' category.
2025-12-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Kim Tai Gyu) and his special relations (family members) in the company 'Vigencell Co., Ltd.' due to gifts and market sales. This falls under the category of Major Shareholding Notification.
2025-12-16 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement from the company '바이젠셀' regarding the setting of a record date for the purpose of holding an Annual General Meeting (AGM). It is a standard corporate notice informing shareholders of the record date (2025-12-31) to determine eligibility for the upcoming 13th AGM. Since it is a regulatory announcement regarding meeting logistics rather than the meeting materials themselves or a full report, it falls under the general regulatory filing category.
2025-12-16 Korean
단일판매ㆍ공급계약체결
Capital/Financing Update Classification · 95% confidence The document is a contract announcement regarding a single sales and supply agreement between the company and a related party (㈜테라베스트). It details contract terms, amounts, payment conditions, and contract duration. There is no financial report, earnings data, or management discussion. The document is a specific transaction announcement related to sales and supply contracts, which fits best under Capital/Financing Update (CAP) as it involves contract terms impacting company capital or revenue streams. The document length is short and focused on a contract, not a report or regulatory filing. Therefore, the classification is CAP with high confidence.
2025-10-01 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.